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A report of the 4th Colmar Scientific Symposium ‘Biology in
the Post-genomic Era’, Colmar, France, 16-17 October 2003.
In genomics, as in life, the rich tend to get richer. Once a
species has had its genome sequenced, it is more likely that
close relatives will have theirs sequenced as well. This helps
biologists collect a great deal of information about an organ-
ism, but it tends to exacerbate the imbalance of genomic
resources. Only those studying these favored organisms can
claim to have entered the ‘post-genomic era’; the rest ask
when this era will arrive.
Even those who work on the ‘elite’ organisms such as mouse
and human are reluctant to concede that we have entered a
post-genomic era. For instance, Jean Weissenbach (Geno-
scope, Evry, France) remarked that he would address
biology in the ‘genomic’ rather than the ‘post-genomic’ era,
pointing out that the human genome has yet to be com-
pletely annotated. Weissenbach described Exofish, a tool
developed in his lab that identifies protein-coding DNA seg-
ments by comparing two genome sequences. Using Exofish,
Weissenbach and his colleagues have compared the draft
genome sequences of the pufferfishes Takifugu and
Tetraodon with mammalian genome sequences. They identi-
fied additional exons within and adjacent to predicted genes
in the mammalian genomes and thus were able to improve
the annotation of the human and mouse genomes. As the
sequences of many genomes are necessary to achieve a fuller
understanding of mammalian genomes, Weissenbach made
a compelling argument that completion of the human and
mouse genome sequences does not necessarily signal the end
of the genomic era.
Plant geneticists would certainly like many more complete
genome sequences. Ralf Reski (Freiburg University, Germany)
addressed the biology of the moss Physcomitrella patens.
This primitive plant, which is a potential food source, has
been engineered to express human proteins without giving
them the plant-specific glycosylations that can make them
allergenic in humans; this may lead to the use of such engi-
neered plants to manufacture and deliver drugs. Further-
more, the haploid genome of Physcomitrella has a high rate
of recombination, which enables gene-targeting approaches
for functional genetic analysis that are not available in, for
example, the model plant Arabidopsis. Thus, there are com-
pelling practical and scientific reasons for obtaining the
genomic sequence of Physcomitrella. 
Although many bacterial genomes have been sequenced, and
more are being completed almost daily, the answer to
whether or not microbiology has entered into the post-
genomic era depends largely on the organisms one wants to
study and the questions one wants to ask. According to Jean-
Michel Claverie (National Centre for Scientific Research
(CNRS), Marseilles, France), there are plenty of microbial
genomic sequences available for potentially identifying new
targets for antibiotics. But, unfortunately, a large number of
genomic sequences does not necessarily yield a large number
of potential targets. On comparing the gene content of
Escherichia coli, Mycobacterium tuberculosis and 36 other
bacterial species, Claverie and colleagues identified only 71
‘core genes’ - genes that are present in all the species and
that are therefore potential targets for broad-spectrum
antibiotics. Of these 71 genes, 52 are linked to translation.
From previous experience only about one in ten proteins is
expected to be ‘druggable’ - that is, to be inhibited by a
potential small-molecule drug. Claverie came to the dis-
heartening conclusion that with only about seven druggable
targets, there are few new broad-spectrum antibiotics on
the horizon. 
Bonnie Bassler (Princeton University, USA) works with a
bacterium whose genome has not been sequenced and prob-
ably will not be sequenced in the near future. She studies
quorum sensing in Vibrio harveyi, which communicates
with members of the same and related species by emittinglight. Quorum sensing is the means by which bacteria assess
population density. Despite the lack of comprehensive
genomic sequence data in V. harveyi, Bassler and her col-
leagues have used comparative genomics to investigate the
signaling systems that regulate light production in response
to quorum-sensing signals. These systems consist of a sensor
protein and an autoinducer, a small molecule that gives an
indication of population density and that is recognized by
the sensor protein. Bassler’s group investigated luxS, a gene
required for the synthesis of the autoinducer in the inter-
species communication system in V. harveyi. They found
homologs of luxS in more than 60 bacterial species, suggest-
ing that inter-species communication is common in both
Gram-positive and Gram-negative bacteria. They also identi-
fied the autoinducer from the discovery that the Borrellia
burgdoferi luxS homolog is in an operon with two genes
required for S-adenosyl methonine synthesis. This provided
the key clue that led to discovery of a catalytic function for
LuxS and identification of the autoinducer asfuranosyl
borate diester.
Much of the meeting focused on the biology of Saccha-
romyces cerevisiae, an organism that has been in the van-
guard of genomics and that is perhaps the only organism
that has truly reached post-genomic status. Not only was it
the first eukaryote to have its genome sequenced, its genome
was nearly the first to be completed, coming in a close
second to the tiny Haemophilus influenzae genome. André
Goffeau (University of Louvain, La Neuve, Belgium), who
initiated and husbanded the international yeast sequencing
effort, observed how the availability of the yeast genome
sequence, coupled with a community of labs poised to
exploit the data, spurred the development of powerful tools
for in-depth study of the yeast cell, such as genome-scale
DNA microarrays, protein arrays, protein-interaction
libraries and collections of gene deletions. 
The power of these tools in yeast was demonstrated by several
speakers. Jim Broach (Princeton University) described how
his group has used DNA-microarray gene-expression profiling
to determine the complete transcriptional output of signaling
networks in response to glucose and other nutrients regulated
by the small GTPase Ras and the phosphatidylinositol kinase
Tor. He also showed that these kinds of experiment are sensi-
tive enough to determine epistatic interactions between com-
ponents of the signaling pathways. 
Marc Vidal (Harvard Medical School, Boston, USA) pre-
sented an analysis of the comprehensive protein-protein
interaction - or ‘interactome’ - maps of yeast and Caenorhab-
ditis elegans. In the yeast interaction network, he found that
‘hubs’ (proteins that interact with many partners) are three
times more likely than other proteins to be encoded by
essential genes. He also distinguished two types of hub,
which he called ‘party’ hubs and ‘date’ hubs. Party hubs
interact simultaneously with many proteins, as determined
by the similar patterns of expression of all the proteins
involved. In contrast, date hubs interact with many different
proteins at different times, as the proteins involved have
very different patterns of expression. Removing the date
hubs from the interaction network reveals sub-networks of
functionally related proteins. Experiments like these are
only possible, however, because the yeast genome has been
extensively and accurately annotated. For other organisms,
gene annotation is more difficult and time-consuming. 
Comparative genome analysis is always helpful in the annota-
tion of a genome, and several current comparative genome-
sequencing projects are aimed at further characterization of
S. cerevisiae. Claude Gaillardin (National Institute of Agron-
omy, Grignon, France) and Bernard Dujon (Pasteur Institute,
Paris, France) described the sequencing of the genomes
of four yeasts (Candida glabrata,  Kluyveromyces lactis,
Debaryomyces hansennii and  Yarrowia lipolytica), repre-
senting major branches of the hemiascomycetes, and the
comparison of these species to S. cerevisiae. These studies
provide a broad overview of how S. cerevisiae relates to other
yeasts in chromosomal number, repeat content (tRNAs,
rDNA repeats and retrotransposons) and gene content.
Mark Johnston (Washington University, St Louis, USA)
described comparative sequencing of five species within the
Saccharomyces genus (S. bayanus, S. castellii, S. kluyveri,
S. kudriavzevii and S. mikatae) with the goal of identifying
conserved intergenic sequences that are likely to regulate
transcription. Comparison of these closely related species
has significantly improved annotation of S. cerevisiae. This
type of study represents a new level of comparative genome
annotation aimed at identifying all functionally conserved
sequences, not just those for protein-coding genes.
The genomic era will persist for many organisms long after
some have entered the post-genomic era. In the meantime,
we should be sensitive to those who do not have a genome
sequence to analyze. 
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